Viking Therapeutics (VKTX) Equity Ratio: 2014-2025
Historic Equity Ratio for Viking Therapeutics (VKTX) over the last 11 years, with Sep 2025 value amounting to 0.96.
- Viking Therapeutics' Equity Ratio fell 0.77% to 0.96 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.96, marking a year-over-year decrease of 0.77%. This contributed to the annual value of 0.97 for FY2024, which is 2.50% up from last year.
- According to the latest figures from Q3 2025, Viking Therapeutics' Equity Ratio is 0.96, which was up 0.36% from 0.96 recorded in Q2 2025.
- Over the past 5 years, Viking Therapeutics' Equity Ratio peaked at 0.98 during Q1 2025, and registered a low of 0.86 during Q4 2022.
- In the last 3 years, Viking Therapeutics' Equity Ratio had a median value of 0.96 in 2025 and averaged 0.96.
- As far as peak fluctuations go, Viking Therapeutics' Equity Ratio fell by 10.02% in 2022, and later rose by 9.65% in 2023.
- Over the past 5 years, Viking Therapeutics' Equity Ratio (Quarterly) stood at 0.96 in 2021, then declined by 10.02% to 0.86 in 2022, then climbed by 9.65% to 0.95 in 2023, then rose by 2.50% to 0.97 in 2024, then declined by 0.77% to 0.96 in 2025.
- Its last three reported values are 0.96 in Q3 2025, 0.96 for Q2 2025, and 0.98 during Q1 2025.